After three years of existence, our Association changed hands and I feel very honoured to be the new President of the EAPCI since September 2009. In this first newsletter as EAPCI President, I believe that this is very appropriate for me to thank the EAPCI Board 2006-2009 for its contribution and at the same time welcome warm heartedly the new team which will help me in facing the challenges ahead of our Association. According to the Statute, most Committee Chairs and members have been renewed and we hope these new energies will help EAPCI to achieve some ambitious goals in the next years.
"We have decided to increase the involvment of national interventional working groups and societies in order to take advantage of the tremendous amount of work already done nationally."
The objectives of the new EAPCI Board will develop along three main areas of interest: clinical research, registries and accreditation. We have decided to increase the involvement of national interventional working groups and societies in order to take advantage of the tremendous amount of work already done nationally in these fields.
The Clinical Initiatives Committee is in charge of one of the main goals in the EAPCI Constitution: « To promote research in the field of percutaneous cardiovascular interventions in Europe and abroad ». Its role will be to:
The nomination of two EAPCI Board members such as Stephan Windecker and Manel Sabate as Chairmen indicate the importance we give to this Committee. We hope to have some proposals to discuss and present already next May in the General Assembly during EuroPCR.
The EAPCI Board is looking at developing a European PCI Registry obtaining a direct transfer of existing PCI databases. Stefan James and Peter Ludman will be in charge of this important project which will require time and effort to become a reality but has enormous potential to track a wide range of questions on how contemporary PCI is being practised in Europe, start quality control, support research and surveillance of new drugs and devices.
While this project is being set up, we will support Bernhard Meier in his effort to continue his annual reports providing the number and type of procedures carried out in the different European countries. A questionnaire will soon reach the different Chairmen of the Working Groups in Interventional Cardiology.
The EAPCI Accreditation Committee chaired by Prof. Martine Gilard is in charge of launching a universally accepted programme of European recognition of Interventional Cardiology training and as such to actively promote the adoption of the European core curriculum and syllabus, in close collaboration with national interventional working groups or societies.
This Committee will work closely with the Web & Communication Committee, chaired by Andreas Baumbach, as well as the Education Committee, chaired by Lino Goncalves.
Last but not least, our Training and Research grant programme. As a result of the economic downturn, in 2010, we were left with very few confirmed grants at the start of my Presidency. We decided Fellowships are so important that we managed to confirm 5 grants to date. EAPCI will support directly one grant from its own budget eroding support for other equally important EAPCI activities because we want to invest in the future European Interventionalists. EuroPCR kindly accepted to waive the registration fees for the 2010 course not only to the Fellows appointed but also to the 5 best applications which have not been selected for a one year of training and/or research in interventional cardiology.
New initiatives initiated during the last three years will be carried forward by the new Board and in particular the Stent for Life project which was launched during EuroPCR 2009 and is entering a critical phase of implementation in 6 countries: France, Spain, Bulgaria, Romania, Greece and Turkey.
Very best regards,
Prof Carlo Di Mario
EAPCI President 2009-2011
Our mission: To reduce the burden of cardiovascular disease
© 2018 European Society of Cardiology. All rights reserved